Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
OPERATING ACTIVITIES    
Net loss $ (20,707) $ (222)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Provision for doubtful accounts 5,641 5,631
Depreciation 6,963 6,895
Loss on disposal of medical equipment 207 641
Gain on sale of medical equipment (1,797) (1,231)
Amortization of intangible assets 5,560 3,849
Asset impairment charges 993
Amortization of deferred debt issuance costs 28 31
Stock-based compensation expense 682 462
Deferred income tax benefit (expense) 15,389 (240)
Changes in Assets - (Increase)/Decrease:    
Accounts receivable (5,445) (4,589)
Inventories 402 (250)
Other current assets (100) (88)
Other assets 119 166
Changes in Liabilities - Increase/(Decrease):    
Accounts payable and other liabilities (352) (3,146)
NET CASH PROVIDED BY OPERATING ACTIVITIES 7,583 7,909
INVESTING ACTIVITIES    
Acquisitions (370)
Purchases of medical equipment (3,299) (5,101)
Purchases of property and equipment (104) (168)
Purchases of intangible assets (192) (3,526)
Proceeds from sale of medical equipment 4,648 3,821
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES 1,053 (5,344)
FINANCING ACTIVITIES    
Principal payments on term loans and capital lease obligations (37,466) (66,999)
Cash proceeds from bank loans and revolving credit facility 28,866 66,892
Debt Issuance Costs (38) (7)
Cash Proceeds - Stock Plans 131 204
Common stock repurchased to satisfy taxes on stock based compensation (58) (75)
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES (8,565) 15
Net change in cash and cash equivalents 71 2,580
Cash and cash equivalents, beginning of year 3,398 818
Cash and cash equivalents, end of year 3,469 3,398
SUPPLEMENTAL DISCLOSURES    
Cash paid for interest 1,200 1,234
Cash paid for income taxes 139 105
NON-CASH TRANSACTIONS    
Additions to medical equipment and property [1] 549 429
Medical equipment acquired pursuant to a capital lease $ 137 $ 2,675
[1] Amounts consist of current liabilities for medical equipment that have not been included in investing activities. These amounts have not been paid for as of December 31, 2017 and 2016, respectively, but will be included as a cash outflow from investing activities for purchases of medical equipment and property when paid.